These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Gromowski GD, Barrett AD. Virology; 2007 Sep 30; 366(2):349-60. PubMed ID: 17719070 [Abstract] [Full Text] [Related]
28. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III. Matsui K, Gromowski GD, Li L, Schuh AJ, Lee JC, Barrett AD. Virology; 2009 Feb 05; 384(1):16-20. PubMed ID: 19101005 [Abstract] [Full Text] [Related]
34. Therapeutic effects of dengue 2 virus capsid protein and staphylococcal nuclease fusion protein on dengue-infected cell cultures. Qin CF, Qin E, Yu M, Chen SP, Jiang T, Deng YQ, Duan HY, Zhao H. Arch Virol; 2005 Apr 05; 150(4):659-69. PubMed ID: 15592886 [Abstract] [Full Text] [Related]
35. Does Japanese encephalitis virus share the same cellular receptor with other mosquito-borne flaviviruses on the C6/36 mosquito cells? Ren J, Ding T, Zhang W, Song J, Ma W. Virol J; 2007 Sep 06; 4():83. PubMed ID: 17803826 [Abstract] [Full Text] [Related]
36. A novel tetraspanin C189 upregulated in C6/36 mosquito cells following dengue 2 virus infection. Lin CC, Yang CF, Tu CH, Huang CG, Shih YT, Chuang CK, Chen WJ. Virus Res; 2007 Mar 06; 124(1-2):176-83. PubMed ID: 17156880 [Abstract] [Full Text] [Related]